Author:
Forbi Joseph C.,Layden Jennifer E.,Phillips Richard O.,Mora Nallely,Xia Guo-liang,Campo David S.,Purdy Michael A.,Dimitrova Zoya E.,Owusu Dorcas O.,Punkova Lili T.,Skums Pavel,Owusu-Ofori Shirley,Sarfo Fred Stephen,Vaughan Gilberto,Roh Hajung,Opare-Sem Ohene K.,Cooper Richard S.,Khudyakov Yury E.
Publisher
Public Library of Science (PLoS)
Reference48 articles.
1. EASL International Consensus Conference on hepatitis C. Paris, 26–27 February 1999. Consensus statement;J Hepatol,1999
2. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;K Mohd Hanafiah;Hepatology,2013
3. Hepatitis C: epidemiology, diagnosis, and management;MS Itskowitz;Compr Ther,2007
4. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection;MS Sulkowski;N Engl J Med,2014
5. Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection;RS Koff;Aliment Pharmacol Ther,2014
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献